Review: taking Prednisone and Vimovo together


Summary

Drug interactions are reported among people who take Prednisone and Vimovo together. This review analyzes the effectiveness and drug interactions between Prednisone and Vimovo. It is created by eHealthMe based on reports of 80 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Prednisone

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. (latest outcomes from Prednisone 224,214 users)

Vimovo

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. (latest outcomes from Vimovo 1,575 users)

On Sep, 17, 2016

80 people who take Prednisone, Vimovo are studied.


Number of reports submitted per year:

Prednisone and Vimovo drug interactions.

Drug effectiveness over time:

Prednisone:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Vimovo:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Prednisone:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Vimovo:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Prednisone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Vimovo:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • pain
  • abdominal pain upper
  • asthma
  • drug ineffective
  • dyspnoea
  • ear infection
  • feeling cold
  • gastroenteritis
  • gastrointestinal ulcer
  • influenza like illness
1 - 6 months:
  • gastrointestinal ulcer
  • horner's syndrome
  • joint pain
  • muscle weakness
  • shaking palsy
6 - 12 months:
  • horner's syndrome
1 - 2 years:
  • urinary tract infection
2 - 5 years:
  • joint pain
  • muscle weakness
  • shaking palsy
not specified:
  • pain
  • fatigue
  • drug ineffective
  • arthralgia
  • dyspnoea
  • malaise
  • rash
  • rheumatoid arthritis
  • hypotension
  • muscular weakness

Most common drug interactions by gender *:

female:
  • pain
  • drug ineffective
  • malaise
  • arthralgia
  • fall
  • fatigue
  • peripheral swelling
  • dyspnoea
  • rheumatoid arthritis
  • musculoskeletal stiffness
male:
  • fatigue
  • anaphylactic reaction
  • chest pain
  • dyspnoea
  • hypotension
  • muscle spasms
  • muscular weakness
  • nephrolithiasis
  • pain
  • pruritus

Most common drug interactions by age *:

30-39:
  • gastrointestinal ulcer
  • arthralgia
  • asthenia
  • back pain
  • c-reactive protein abnormal
  • crepitations
  • depression
  • dermatitis allergic
  • fatigue
  • hepatic steatosis
40-49:
  • osteopenia
  • pain
  • alanine aminotransferase increased
  • blood pressure diastolic increased
  • bone disorder
  • bone loss
  • cataract
  • cerebrovascular accident
  • chronic obstructive pulmonary disease
  • haematuria
50-59:
  • arthralgia
  • drug ineffective
  • malaise
  • pain
  • hypoglycaemia
  • renal tubular necrosis
  • arthropathy
  • blood cholesterol increased
  • cough
  • diarrhoea
60+:
  • arthritis
  • fall
  • gait disturbance
  • gastrointestinal haemorrhage
  • malaise
  • osteonecrosis of jaw
  • pain in extremity
  • rheumatoid arthritis
  • urinary tract infection
  • abdominal distension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Prednisone and Vimovo?

Can you answer these questions?

More questions for: Prednisone, Vimovo

You may be interested in these reviews

More reviews for: Prednisone, Vimovo

On eHealthMe, Prednisone (prednisone) is often used to treat rheumatoid arthritis. Vimovo (esomeprazole magnesium; naproxen) is often used to treat osteoarthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.